GT, 4D Pharma deal

4d pharma acquired 37.5% of GT Biologics for 699,500 new 4d pharma shares at L1.75 per share, or about L1.2 million ($2.1 million). 4d pharma now owns 83.5% of GT Biologics. GT Biologics’ lead product...